Colloidal carriers for ophthalmic drug delivery

Area of Science:

• Ophthalmology and Pharmaceutical Sciences
• Drug Delivery Systems

Background:

• Ocular drug delivery faces challenges with poor bioavailability from topical applications due to pre-corneal factors.
• Current intravitreal injections for posterior segment diseases carry high complication risks, especially with repeated administrations.
• There is a critical need for advanced drug delivery systems to overcome these limitations.

Purpose of the Study:

• To review recent advancements in colloidal drug delivery systems for ocular applications.
• To discuss the development issues and benefits of using colloidal carriers for sustained ocular drug delivery.
• To highlight the potential of liposomes, niosomes, nanoparticles, and microemulsions in improving ocular drug therapy.

Main Methods:

• Literature review of recent progress in colloidal drug delivery systems for ocular use.
• Analysis of development issues and specific challenges associated with these systems.
• Discussion of the benefits of colloidal carriers in intravitreal injections for posterior drug delivery.

Main Results:

• Colloidal carriers (liposomes, niosomes, nanoparticles, microemulsions) show promise for sustained ocular drug delivery.
• These systems can potentially enhance drug bioavailability and reduce the need for frequent intravitreal injections.
• Investigating these carriers addresses the limitations of conventional topical and injection-based ocular therapies.

Conclusions:

• Colloidal drug delivery systems offer a promising strategy to improve ocular drug bioavailability and therapeutic outcomes.
• Further research and development in liposomes, niosomes, nanoparticles, and microemulsions are crucial for advancing ocular drug delivery.
• Sustained-release colloidal formulations can mitigate risks associated with repeated intravitreal injections for posterior segment ocular diseases.